about
Real world outcomes of pomalidomide for treatment of relapsed light chain amyloidosisCytomegalovirus reactivation after bortezomib treatment for multiple myeloma and light chain amyloidosisLong-term clinical outcomes in a cohort of patients with solitary plasmacytoma treated in the modern eraCarfilzomib is an effective upfront treatment in AL amyloidosis patients with peripheral and autonomic neuropathyA 24-year experience of autologous stem cell transplantation for light chain amyloidosis patients in the United Kingdom
P50
description
researcher (ORCID 0000-0002-5908-0645)
@en
name
Faye A Sharpley
@en
type
label
Faye A Sharpley
@en
prefLabel
Faye A Sharpley
@en
P31
P496
0000-0002-5908-0645